Effects of a Dietary Fiber on Fecal Microbiota and Metabolism

NCT ID: NCT01518088

Last Updated: 2016-04-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-02-29

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to examine how a dietary fiber affects metabolism in healthy overweight and obese adults. The fiber will be added to foods that participants will consume for two, three-week periods. The fiber will be given in two doses -- 15 g per day during one period, and 30 g per day in the other. In another three-week period, they will consume the same foods, but with no fiber added. Major outcomes will include fermentability of the fiber, as assessed by measurement of breath hydrogen, as well as shifts in fecal bacteria. The caloric value of the fiber will be determined and metabolic measures related to blood glucose control and inflammation will also be taken.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Focus of the Study is on Gut Health

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low dose dietary fiber

Group Type EXPERIMENTAL

Dietary Fiber

Intervention Type DIETARY_SUPPLEMENT

Dietary fiber will be added to study foods

High dose dietary fiber

Group Type EXPERIMENTAL

Dietary Fiber

Intervention Type DIETARY_SUPPLEMENT

Dietary fiber will be added to study foods

No added fiber

Group Type PLACEBO_COMPARATOR

Dietary Fiber

Intervention Type DIETARY_SUPPLEMENT

Dietary fiber will be added to study foods

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dietary Fiber

Dietary fiber will be added to study foods

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Body mass index from 25 to 35 kg/m2.
* Willing to consume study foods and comply with dietary exclusions and specimen collection

Exclusion Criteria

* Pregnancy
* Diabetes
* Gastrointestinal disease
* Regular use of pre- or probiotics
* Recent use of antibiotics
* High intake of dietary fiber
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ingredion Incorporated

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nancy Keim, PhD

Role: PRINCIPAL_INVESTIGATOR

ARS/USDA, University of California - Davis

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

USDA, ARS, Western Human Nutrition Research Center

Davis, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PRT002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Fiber Effects on Glycemic Index
NCT02831738 COMPLETED NA